|
HY-100002-10mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-100mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-25mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-5mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-50mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-10mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-5mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-50mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-10mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-100mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-2mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-25mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-5mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-50mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101880-1mg
|
MedChemexpress LLC
|
ADHP [CAS 119171-73-2]
|
|
|
|
|
HY-101880-5mg
|
MedChemexpress LLC
|
ADHP [CAS 119171-73-2]
|
|
|
|
|
HY-112841-10mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-100mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-25mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-5mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-50mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-500mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-113402-10mg
|
MedChemexpress LLC
|
Gamma-glutamylcysteine [CAS 636-58-8]
|
|
COVID-19-anti-virus
|
|
|
HY-113402-25mg
|
MedChemexpress LLC
|
Gamma-glutamylcysteine [CAS 636-58-8]
|
|
COVID-19-anti-virus
|
|
|
HY-113402-5mg
|
MedChemexpress LLC
|
Gamma-glutamylcysteine [CAS 636-58-8]
|
|
COVID-19-anti-virus
|
|
